Total Payments
$7,579
2024 Payments
$1,916
Companies
47
Transactions
410
Medicare Patients
1,728
Medicare Billing
$124,795
Payment Breakdown by Category
Food & Beverage$7,513 (99.1%)
Education$65.99 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,513 | 409 | 99.1% |
| Education | $65.99 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,003 | 68 | $0 (2024) |
| ABBVIE INC. | $990.22 | 61 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $849.79 | 24 | $0 (2024) |
| Lilly USA, LLC | $573.98 | 38 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $508.96 | 25 | $0 (2024) |
| Abbott Laboratories | $406.26 | 12 | $0 (2024) |
| Amgen Inc. | $374.21 | 20 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $234.07 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $224.98 | 10 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $173.94 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,916 | 95 | ABBVIE INC. ($271.08) |
| 2023 | $1,870 | 93 | Bayer Healthcare Pharmaceuticals Inc. ($249.53) |
| 2022 | $2,094 | 109 | Novo Nordisk Inc ($351.44) |
| 2021 | $1,699 | 113 | AstraZeneca Pharmaceuticals LP ($390.00) |
All Payment Transactions
410 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Obesity | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.41 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $17.69 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 11/13/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: VACCINES | ||||||
| 11/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: DIABETES | ||||||
| 11/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: PAIN | ||||||
| 10/22/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $30.89 | General |
| Category: Endocrinology | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Diabetes Care | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Oncology | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Obesity | ||||||
| 09/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 437 | 528 | $151,409 | $37,292 |
| 2022 | 12 | 459 | 543 | $139,952 | $35,778 |
| 2021 | 11 | 418 | 498 | $125,502 | $30,661 |
| 2020 | 12 | 414 | 483 | $108,249 | $21,064 |
Total Patients
1,728
Total Services
2,052
Medicare Billing
$124,795
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 157 | 225 | $76,206 | $14,895 | 19.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 64 | 64 | $22,984 | $6,840 | 29.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 24 | 24 | $17,256 | $6,726 | 39.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 41 | $18,113 | $4,102 | 22.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 17 | 19 | $2,451 | $1,353 | 55.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 30 | $7,237 | $1,305 | 18.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $1,824 | $725.76 | 39.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 21 | $1,596 | $635.04 | 39.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 23 | 23 | $1,242 | $345.92 | 27.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 31 | $2,152 | $278.10 | 12.9% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 13 | 13 | $221.00 | $57.28 | 25.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 13 | 13 | $127.00 | $28.60 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 144 | 203 | $65,772 | $13,486 | 20.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 65 | 65 | $22,685 | $7,110 | 31.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 44 | 54 | $23,598 | $5,294 | 22.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 13 | 13 | $9,347 | $3,615 | 38.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 35 | 36 | $4,644 | $2,451 | 52.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 23 | $5,060 | $1,184 | 23.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 37 | 38 | $2,888 | $1,093 | 37.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 21 | 21 | $1,596 | $603.65 | 37.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 37 | 37 | $1,998 | $561.85 | 28.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 21 | $1,596 | $189.45 | 11.9% |
| 69209 | Removal of impacted ear wax by washing | Office | 2022 | 15 | 16 | $608.00 | $154.03 | 25.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 15 | 16 | $160.00 | $35.51 | 22.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 132 | 186 | $60,264 | $12,609 | 20.9% |
About Tanya Kirpalani, PA-C
Tanya Kirpalani, PA-C is a Chronic Disease Hospital healthcare provider based in Clermont, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2011. The National Provider Identifier (NPI) number assigned to this provider is 1982993143.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tanya Kirpalani, PA-C has received a total of $7,579 in payments from pharmaceutical and medical device companies, with $1,916 received in 2024. These payments were reported across 410 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($7,513).
As a Medicare-enrolled provider, Kirpalani has provided services to 1,728 Medicare beneficiaries, totaling 2,052 services with total Medicare billing of $124,795. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Chronic Disease Hospital
- Other Specialties Medical
- Location Clermont, FL
- Active Since 03/28/2011
- Last Updated 05/26/2020
- Taxonomy Code 281P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1982993143
Products in Payments
- FARXIGA (Drug) $653.08
- Ozempic (Drug) $546.51
- Kerendia (Drug) $508.96
- UBRELVY (Drug) $294.05
- QULIPTA (Drug) $268.08
- JARDIANCE (Drug) $266.49
- MOUNJARO (Drug) $250.90
- VRAYLAR (Drug) $239.71
- FREESTYLE LIBRE 3 (Device) $206.96
- SUNOSI (Drug) $173.94
- Otezla (Drug) $172.42
- Aimovig (Biological) $171.56
- Wegovy (Drug) $167.07
- AIRSUPRA (Drug) $164.15
- FREESTYLE LIBRE 2 (Device) $158.12
- Azstarys (Drug) $140.44
- NURTEC ODT (Drug) $133.60
- EMGALITY (Drug) $132.84
- SPRAVATO (Drug) $131.36
- REXULTI (Drug) $127.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.